Caption Management, LLC Apellis Pharmaceuticals, Inc. Transaction History
Caption Management, LLC
- $8.03 Billion
- Q2 2025
A detailed history of Caption Management, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 515,000 shares of APLS stock, worth $12.3 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
515,000
Previous 140,000
267.86%
Holding current value
$12.3 Million
Previous $3.06 Million
191.21%
% of portfolio
0.11%
Previous 0.03%
Shares
13 transactions
Others Institutions Holding APLS
# of Institutions
295Shares Held
132MCall Options Held
2.97MPut Options Held
623K-
Avoro Capital Advisors LLC New York, NY12.2MShares$291 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$283 Million17.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$242 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.75MShares$232 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.98MShares$214 Million0.03% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.61B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...